EC
NARI

EntryPoint Capital’s Inari Medical, Inc. Common Stock NARI Stock Holding History

EntryPoint Capital’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,595
Closed -$388K – 1000
2024
Q4 		$388K Buy
+7,595
New +$373K 0.16% 219
2024
Q3 		– Sell
-2,316
Closed -$112K – 1228
2024
Q2 		$112K Buy
+2,316
New +$103K 0.16% 267

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

EntryPoint Capital's NARI Position: Q1 2025 in Review

EntryPoint Capital sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 7,595 shares — an estimated $388K sold.

EntryPoint Capital first reported a position in NARI in Q2 2024 and held it in 2 quarters. The position peaked at $388K in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • EntryPoint Capital reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • EntryPoint Capital sold 7,595 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $388K.
  • EntryPoint Capital first reported a position in Inari Medical, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • EntryPoint Capital's Inari Medical, Inc. Common Stock position peaked at $388K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.